RA drugs under the microscope: which one keeps you stronger?
NCT ID NCT07182630
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at how two types of rheumatoid arthritis (RA) drugs—anti-TNF-α and non-TNF-α—affect patients' aerobic capacity, muscle strength, fatigue, and heart disease risk factors. Researchers will measure oxygen use during exercise, muscle strength, and disease activity in 40 adults aged 18-65 who have been on these drugs for 1-3 years. The goal is to understand which treatment better supports physical fitness and overall health in RA patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
anti-TNF-α and non-TNF-α drugs
What this could lead to
If successful, this study could help doctors choose RA treatments that better preserve patients' physical fitness and reduce heart disease risk.
What could go wrong
This is a small, early-stage observational study with only 40 participants, so results may not apply to all RA patients. It measures changes but does not test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS (RA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fırat University
Elâzığ, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••